Skip to content

Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

Remote Controlled CT Scanning for Decentralized Diagnostics and Treatment Versus Standard Care in Acute Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07530588
Acronym
DIRECT-CT
Enrollment
52
Registered
2026-04-15
Start date
2025-07-17
Completion date
2028-12-31
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Rural, Prehospital diagnostics and treatment, Remote controlled computer tomography, Intravenous thrombolysis, District medical center

Brief summary

The DIRECT-CT trial is designed to test the hypothesis that remote controlled CT scanning combined with real time audio-and video conference (AVC) guided assessment from an experienced hospital stroke team (tele-stroke) at decentralized medical centers (DMC) reduces time to intravenous thrombolytic treatment compared to the standard pathway.

Detailed description

Intravenous thrombolysis (IVT) treatment is an effective treatment of disabling acute ischemic stroke (AIS) and leads to improved functional outcomes if administered within 4.5 hours after symptom onset. Since the treatment effect is highly time dependent, it is recommended to give IVT as soon as possible after symptom onset to patients with AIS without contraindications. A CT examination of the head must be performed prior to IVT to exclude intracranial hemorrhage. If an intracerebral hemorrhage (ICH) is detected rapid blood pressure lowering medication should be initiated. As of today, timely delivery of acute stroke treatment is challenging in several parts of Norway due to sparsely populated areas with long geographical distances between hospitals. Patients living in rural areas are at risk of not receiving timely acute stroke treatment. Due to the time sensitive nature of IVT, a decentralized approach to diagnostics and treatment is compelling. However, a CT scanner and medical expertise on acute stroke diagnostics and treatment is not readily available in pre-hospital settings in Norway. Investigators therefore plan to 1) assess the feasibility of widespread implementation of a model with decentralized stroke diagnostics and treatment in rural areas with a stationary CT combined with audio-and video guided support from an experienced stroke team at the local hospital 2) compare treatment access, time metrics and outcomes for stroke patients in the DMC catchment area to patients from similar rural areas without access to decentralized diagnostics and treatment. The risk for patients is minimized through remote controlled CT scanning administered from the local hospital combined with tele-stroke guided assessment by an experienced stroke team and regular simulation trainings. All treatment, including thrombolytic therapy, and monitoring routines are performed according to the hospitals' standard operating procedures (SOP). The primary objective is to compare time from Emergency Medical Communication (EMC) notification to IVT treatment between AIS patients in the intervention group comprising patients from geographical areas with an established service of prehospital stroke diagnostics and treatment at the DMC to the control group comprising patients from similar geographical areas undergoing diagnostics and treatment at their local hospital as per standard pathway.

Interventions

OTHERDecentralized diagnostics and treatment

The intervention includes admittance to the DMC for initial diagnostic work up and acute treatment (if indicated). Paramedics examine the patient and assess stroke severity by NIHSS and G-FAST scoring overseen by a stroke physician at the local hospital through real time video conference. A remote controlled CT scan of the head is conducted, and the stroke team at the local hospital evaluates results and makes a treatment decision in real-time AVC. If treatment is indicated, this is administered by local personnel at the DMC before initiating transport to the local hospital or the comprehensive stroke center in case of LVO. Patients who are unable to reach the DMC prior to estimated admission time at their local hospital, will be treated at their local hospital as per standard pathway.

Sponsors

University Hospital of North Norway
Lead SponsorOTHER
Helgelandssykehuset Hospital Trust
CollaboratorUNKNOWN
Nordlandssykehuset Hospital Trust
CollaboratorUNKNOWN
Finnmarkssykehuset HF
CollaboratorUNKNOWN
UiT The Arctic University of Norway
CollaboratorOTHER
Innlandet Central Hospital HF, Lillehammer
CollaboratorUNKNOWN
Oslo University Hospital
CollaboratorOTHER
Ringerike hospital HF, Hønefoss Norway
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This is a prospective open label, parallel group controlled observational clinical study investigating the effect of a health service innovation. The study assesses the superiority of a model with prehospital remote controlled CT scanning combined with telestroke guided assessment for decentralized diagnostics and acute stroke treatment at the DMCs compared to the standard pathway for stroke patients in rural Norway.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients in the catchments areas of the intervention and control group presenting with a clinical suspected diagnosis of stroke within symptom onset within the last 24 hours

Exclusion criteria

\- Patients presenting with a clinical suspected diagnosis of stroke more than 24 hours after symptom onset

Design outcomes

Primary

MeasureTime frameDescription
Time from EMC notification to initiation IVT treatmentDay 0The time from Emergency Medical Communication notification to initiation intravenous thrombolysis treatment in eligible patients

Secondary

MeasureTime frameDescription
Time from admittance to initiation of IVT treatment (door-to-needle time)Day 0Time from admittance to initiation of IVT treatment (door-to-needle time) in eligible patients
Time from admittance to start of blood pressure lowering medication in ICH patientsDay 0Time from admittance to start of blood pressure lowering medication in ICH patients patients
Proportion of AIS patients receiving IVT treatment (y/n)Day 0Proportion of acute ischaemic stroke patients receiving IVT treatment (y/n)
Proportion of AIS patients receiving EVT treatment (y/n)Day 0Proportion of acute ischaemic stroke patients receiving endovascular treatment
Proportion of patients achieving early neurological improvementDay 1Early neurological improvement, defined as a reduction of ≥8 points on the NHISS, or NIHSS score of 0-1 at 24 hours (22-36 h) (y/n)
mRS score at 90 daysMonth 3functional outcome measured by the modified Rankin Scale score (mRS) at discharge and day 90 (± 2 weeks) • mRS category at day 90 (+/- 2 weeks) * excellent functional outcome (mRS 0-1) at day 90 (+/- 2 weeks) * good functional outcome (mRS 0-2) at day 90 (+/- 2weeks) * poor functional outcome (mRS 5-6) at day 90 (+/- 2 weeks)
Proportion of patients with symptomatic intracranial hemorrhage (sICH)Day 1Proportion of patients with symptomatic intracranial hemorrhage (sICH) complications defined as intracranial hemorrhage on CT/MRI within 36 hours post IVT causally related to an increase of 4 points or more on the NIHSS (y/n)
Time from symptom onset to groin puncture timeDay 0Time from symptom onset to groin puncture time in patients undergoing thrombectomy
Transportation mode (ground or air ambulance)Day 0Transportation mode to primary or comprehensive stroke centre
MortalityYear 1Mortality during hospitalization, 30 days, 90 days and 1 year
Final diagnosisWeek 2The final discharge diagnosis

Countries

Norway

Contacts

CONTACTAgnethe Eltoft, MD, PhD
agnethe.eltoft@unn.no+4797193417
CONTACTEivor Logstein, MD
Eivor.Logstein@Helgelandssykehuset.no
STUDY_DIRECTORTor Ingebrigtsen, MD, PhD

University Hospital of North Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026